September 3, 2021 by admin 0 Comments

3D Bioprinting is Medicine’s Next Frontier

Biomedicine’s next frontier

The growing push for 3-D tissue models is limited by challenges in automated handling,
processing and scalability of the technology to various types of materials
and high-throughput applications. To meet these challenges,
4D bioprinting and human-cell derived ECM bioinks can allow researchers
to biologically mimic the formation of complex, heterogeneous 3-D structures
and to scale the technology to high-throughput and clinically translatable applications.

This webinar will discuss the latest megatrends behind bioprinting developments as well as scientific
and medical applications developed for tissue engineering, regenerative medicine,
preclinical screening and testing, veterinary medicine,
as well as personalized drug and food development.

For more details, please join the open innovation webinar.

Da-Yae Lee

  • Senior Bio-Consultant, ROKIT Healthcare

Career Highlight

  • Biochemistry and Molecular Biology, Smith College
  • Clinical Research Coordinator, Brigham and Women’s Hospital
  • Research Support Associate, MIT Koch Center for Integrative Cancer Research
3D Bioprinting is Medicine’s Next Frontier
8, Sep, 2021, 9:00 AM – 11:00 AM (EDT)
Live Platform
If you want to join this webinar, please press the button below.